CAPR vs TECH
Capricor Therapeutics Inc (CAPR) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Capricor Therapeutics Inc (CAPR) is a biotechnology company listed on NASDAQ.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported CAPR revenue for 2024-12-31 was $22.3M. Net income was -$40.5M. Revenue was down 11.5% from 2023-12-31 to 2024-12-31. CAPR currently screens at market cap $1.62B.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
CAPR currently screens at market cap $1.62B. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the CAPR and TECH stock pages for the full models.
Not investment advice.